Search

Your search keyword '"Potenza, Domenico"' showing total 196 results

Search Constraints

Start Over You searched for: Author "Potenza, Domenico" Remove constraint Author: "Potenza, Domenico"
196 results on '"Potenza, Domenico"'

Search Results

1. The Role of TOMM40 in Cardiovascular Mortality and Conduction Disorders: An Observational Study

4. Involvement of APOE in Incidence of Revascularization in Patients Affected by Peripheral Arterial Disease: A Prospective Study from Southern Italy

5. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

9. Pharmacogenomics of Pediatric Cardiac Arrest: Cisplatin Treatment Worsened by a Ryanodine Receptor 2 Gene Mutation

10. Stone and time. Permanenza e mutamento

11. Phenotypic Variability of a Pathogenic PKP2 Mutation in an Italian Family Affected by Arrhythmogenic Cardiomyopathy and Juvenile Sudden Death: Considerations From Molecular Autopsy to Sport Restriction

12. Ablation for longstanding permanent atrial fibrillation: Results from a randomized study comparing three different strategies

13. Pulmonary-vein isolation for atrial fibrillation in patients with heart failure

14. Pulmonary Vein Antral Isolation Using an Open Irrigation Ablation Catheter for the Treatment of Atrial Fibrillation: A Randomized Pilot Study

18. Clinical and economic impact of multipoint left ventricular pacing: A comparative analysis from the Italian registry on multipoint pacing in cardiac resynchronization therapy (IRON‐MPP)

19. Impact of multipoint pacing on projected battery longevity in cardiac resynchronization therapy. An IRON‐MPP study sub‐analysis

20. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation

22. Embolic Events and Char Formation During Pulmonary Vein Isolation in Patients with Atrial Fibrillation: Impact of Different Anticoagulation Regimens and Importance of Intracardiac Echo Imaging

23. Electrocardiogram in Friedreich's ataxia: A short‐term surrogate endpoint for treatment efficacy.

24. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

25. Correction: SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience

26. Double missense mutations in cardiac myosin‐binding protein C and myopalladin genes: A case report with diffuse coronary disease, complete atrioventricular block, and progression to dilated cardiomyopathy

29. Timing of clopidogrel loading dose on peripheral blood endothelial progenitor cells, SDF-1α and neointimal hyperplasia in carotid stenting

30. Real-life outcome of implantable cardioverter-defibrillator and cardiac resynchronization defibrillator replacement/upgrade in a contemporary population: observations from the multicentre DECODE registry

31. SVR12 rates higher than 99% after sofosbuvir/velpatasvir combination in HCV infected patients with F0-F1 fibrosis stage: A real world experience

34. Sudden death in mild hypertrophic cardiomyopathy with compound DSG2/DSC2/MYH6 mutations: Revisiting phenotype after genetic assessment in a master runner athlete

35. Serum uric acid as a prognostic marker in the setting of advanced vascular disease: a prospective study in the elderly

36. Detect Long-term Complications after ICD Replacement (DECODE): Rationale and Study Design of a Multicenter Italian Registry

37. Double missense mutations in cardiac myosin-binding protein C and myopalladin genes: A case report with diffuse coronary disease, complete atrioventricular block, and progression to dilated cardiomyopathy.

38. Sudden cardiac death in J wave syndrome with short QT associated to a novel mutation in Nav 1.8 coding gene SCN10A: First case report for a possible pharmacogenomic role

39. Real life rates of sustained virological response (SVR) and predictors of relapse following DAA treatment in genotype 3 (GT3) patients with advanced fibrosis/cirrhosis

40. Appropriate implantable cardioverter-defibrillator interventions in cardiac resynchronization therapy–defibrillator (CRT-D) patients undergoing device replacement: time to downgrade from CRT-D to CRT-pacemaker? Insights from real-world clinical practice in the DECODE CRT-D analysis

41. Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study

42. Sofosbuvir and ribavirin for genotype 2 HCV infected patients with cirrhosis: A real life experience

43. Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy

44. GW27-e0796 Vitamin D level and myocardial revascularization in patients affected by peripheral artery disease: a prospective study

45. A Silent Alarm at Occupational Evaluation Two Months after a Normal Painful ECG: A Case of Wellens’ syndrome

46. Device Longevity in a Contemporary Cohort of ICD/CRT‐D Patients Undergoing Device Replacement

47. 89-07: Multipoint pacing via a quadripolar left ventricular lead: Preliminary results from an Italian Registry

48. 169-01: Downgrading from CRT-D to CRT-P at the time of battery depletion: preliminary results from DECODE Registry Trial

49. 176-56: Intraprocedural complications at the time of ICD replacement: Insights from the DECODE registry

50. 57-01: Electrical remodeling of repolarization abnormality after surgical treatment in pheochromocytoma: a retrospective analysis

Catalog

Books, media, physical & digital resources